Skip to content

The Role of Resistance Exercise in Chronic Obstructive Pulmonary Disease Exacerbation

Impact of Resistance Training During Hospitalization in COPD Patients: a Randomized and Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01786928
Acronym
RECOPD
Enrollment
34
Registered
2013-02-08
Start date
2009-04-30
Completion date
2010-10-31
Last updated
2013-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

chronic obstructive pulmonary disease, exacerbation, resistance training, muscle force

Brief summary

The purpose of this study is to determine whether resistance exercise are effective in combating the decline in muscle strength during an exacerbation of Chronic Obstructive Pulmonary Disease (COPD).

Detailed description

Acute exacerbations are common in patients with COPD and cause specific signs and symptoms, such as increased dyspnea, productive cough with altered sputum, and fever. With disease progression, exacerbations are frequent and have a negative impact on health related quality of life and pulmonary function as well as increase mortality. More severe exacerbations require hospitalization resulting in enormous health expenditures, severely reducing daily life activities and declining peripheral muscle strength that can be only partially reversed after 3 months. Despite many features have been pointed out as responsible for the decrease in muscle strength during hospitalization, physical inactivity seems the most important. Resistance training is an interesting therapeutic option to prevent and/or reverse muscular dysfunction due to immobilised in healthy subjects and stable COPD patients because induces hypertrophy of type II fibers, increases muscle strength and exercise tolerance. In addition, provokes lower dyspnea perception during effort compared with other exercise training. Despite these benefits for stable COPD, the impact of a resistance exercise program during hospitalization remains poorly known.

Interventions

OTHERResistance training

Resistance training group received training program for upper (shoulder flexion and abduction and biceps) and lower limbs (knee extension and flexion and hip flexion). Daily exercise for every muscle was performed with free weights at 80% of an maximal repetition test and a 4 minutes rest was allowed between each step.

Sponsors

Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients hospitalized for exacerbation of COPD

Exclusion criteria

* patients presenting change in mental status (confusion, lethargy or coma) * persistence or worsening in hypoxemia (PaO2\<40mmHg) and/or respiratory acidosis (pH\<7.25) despite oxygen supplementation or use of non-invasive ventilation * hemodynamic instability requiring vasoactive drugs * patients transferred to ICU * hospitalization lower than 5 days * diseases that prevented the exercises

Design outcomes

Primary

MeasureTime frameDescription
The benefits of resistance training during exacerbation of COPD on peripheral muscle strength during hospitalizationWill be evaluated on the second day of hospitalization, the day of hospital discharge (this time interval must be longer than five days)The metric used to evaluate the strength gain is given in kilogram (absolute value) and percentage relative to that obtained on the second hospital day

Secondary

MeasureTime frameDescription
The benefits of resistance training during exacerbation of COPD on physical activity in daily lifeWill be evaluated in the third and fifth day of hospitalization and thirty days after dischargeThe metric used to evaluate the changes will be given in minutes and percentage of total time

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026